How has been the historical performance of Medinova Diagno.?

Answer:The historical performance of Medinova Diagno shows fluctuations in key financial metrics over the years, with a notable decline in net sales and profit margins in recent periods.

Breakdown:
Medinova Diagno's net sales have decreased from 13.20 Cr in Mar'22 to 9.81 Cr in Mar'25, reflecting a downward trend over the last few years. Total operating income followed a similar pattern, peaking at 13.20 Cr in Mar'22 and dropping to 9.81 Cr by Mar'25. The company's total expenditure, excluding depreciation, also decreased from 9.49 Cr in Mar'22 to 6.82 Cr in Mar'25, contributing to an operating profit (PBDIT) that improved from 1.20 Cr in Mar'20 to 2.99 Cr in Mar'25. However, profit before tax showed a slight increase to 2.50 Cr in Mar'25 from 2.28 Cr in Mar'24, while profit after tax decreased to 1.90 Cr in Mar'25 from 2.00 Cr in Mar'24. The company's total assets rose from 3.85 Cr in Mar'22 to 6.57 Cr in Mar'25, alongside total liabilities increasing from 3.85 Cr to 6.57 Cr in the same period. Cash flow from operating activities remained stable at 2.00 Cr from Mar'24 to Mar'25, indicating consistent operational cash generation despite the challenges in sales and profitability.